What does Dr. Thomas Verschueren do?

Dr. Thomas Verschueren is a specialist medical practice in Kortrijk. Private Limited, started on 19 January 2021, 1 establishment.

What is the address of Dr. Thomas Verschueren?

The registered office of Dr. Thomas Verschueren is located at Koning Albertpark(Kor) 29, 8500 Kortrijk.

Is Dr. Thomas Verschueren still active?

Yes. According to the CBE (17 September 2026) Dr. Thomas Verschueren is active, legal situation “Normale toestand”, started on 19 January 2021.

Is Dr. Thomas Verschueren registered on Peppol?

Yes, Dr. Thomas Verschueren is registered on the Peppol network with ID 0208:0761796824.

What is the enterprise number of Dr. Thomas Verschueren?

The enterprise number of Dr. Thomas Verschueren is BE0761796824.

When was Dr. Thomas Verschueren founded?

Dr. Thomas Verschueren was founded on 19 January 2021.

Who are the directors of Dr. Thomas Verschueren?

According to the 2025 annual accounts, the directors of Dr. Thomas Verschueren are: Thomas VERSCHUEREN.

Is Dr. Thomas Verschueren a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 January 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Thomas Verschueren make in 2025?

Dr. Thomas Verschueren posted a profit after taxes of € 190,600 in financial year 2025.

What is the revenue of Dr. Thomas Verschueren?

As a small company, Dr. Thomas Verschueren is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 350,640.

Dr. Thomas Verschueren (Private Limited) - Kortrijk

Dossier Dr. Thomas Verschueren, printed on 17 September 2026 from databakkes.be/en/0761796824/dr-thomas-verschueren. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 38 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Thomas Verschueren from Kortrijk, company number BE0761796824, closed financial year 2025 with a result of € 190,600 after tax. For that financial year Dr. Thomas Verschueren recorded a gross margin of € 350,640 and equity of € 5,394. Compared with financial year 2024, the result moved from € 209,700 to € 190,600. The company is profitable. The buffer shrank hard: equity is 96 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.

What it is worth Shrank hard

€ 5,394

▼ 96% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 190,600

▼ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 70,404

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 307,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 15,089

▼ 1% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 14 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.2 million

▼ 6% vs 2024

€ 86,277 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.

Owed to suppliers

€ 1,606

▼ 59% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 50,445

▼ 29% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 66,248 Gross margin 2022: € 66,248 First fiscal year in the series	€ 166,449 Gross margin 2023: € 166,449 ▲ 151% vs 2022 (€ 66,248) Favourable step	€ 286,463 Gross margin 2024: € 286,463 ▲ 72% vs 2023 (€ 166,449) Favourable step	€ 350,640 Gross margin 2025: € 350,640 ▲ 22% vs 2024 (€ 286,463) Favourable step	▲ 22%
Profit after taxes	€ 50,441 Profit after taxes 2022: € 50,441 First fiscal year in the series	€ 126,172 Profit after taxes 2023: € 126,172 ▲ 150% vs 2022 (€ 50,441) Favourable step	€ 209,700 Profit after taxes 2024: € 209,700 ▲ 66% vs 2023 (€ 126,172) Favourable step	€ 190,600 Profit after taxes 2025: € 190,600 ▼ 9% vs 2024 (€ 209,700) Unfavourable step	▼ 9%
Equity	€ 73,172 Equity 2022: € 73,172 First fiscal year in the series	€ 110,594 Equity 2023: € 110,594 ▲ 51% vs 2022 (€ 73,172) Favourable step	€ 121,794 Equity 2024: € 121,794 ▲ 10% vs 2023 (€ 110,594) Favourable step	€ 5,394 Equity 2025: € 5,394 ▼ 96% vs 2024 (€ 121,794) Unfavourable step	▼ 96%
Total debts	€ 35,173 Total debts 2022: € 35,173 First fiscal year in the series	€ 40,988 Total debts 2023: € 40,988 ▲ 17% vs 2022 (€ 35,173) Unfavourable step	€ 1,393,549 Total debts 2024: € 1,393,549 ▲ € 1.4 million vs 2023 (€ 40,988) Unfavourable step	€ 1,438,821 Total debts 2025: € 1,438,821 ▲ 3% vs 2024 (€ 1,393,549) Unfavourable step	▲ 3%
Cash	€ 38,610 Cash 2022: € 38,610 First fiscal year in the series	€ 76,891 Cash 2023: € 76,891 ▲ 99% vs 2022 (€ 38,610) Favourable step	€ 69,904 Cash 2024: € 69,904 ▼ 9% vs 2023 (€ 76,891) Unfavourable step	€ 70,404 Cash 2025: € 70,404 ▲ 1% vs 2024 (€ 69,904) Favourable step	▲ 1%
Land & buildings	-	-	€ 1,273,218 Land & buildings 2024: € 1,273,218 First fiscal year in the series	€ 1,226,699 Land & buildings 2025: € 1,226,699 ▼ 4% vs 2024 (€ 1,273,218) Unchanged	▼ 4%
Retained profit	€ 68,172 Retained profit 2022: € 68,172 First fiscal year in the series	€ 105,594 Retained profit 2023: € 105,594 ▲ 55% vs 2022 (€ 68,172) Favourable step	€ 116,794 Retained profit 2024: € 116,794 ▲ 11% vs 2023 (€ 105,594) Favourable step	€ 394 Retained profit 2025: € 394 ▼ € 116,400 vs 2024 (€ 116,794) Unfavourable step	▼ € 116,400
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 88,750 Dividend 2023: € 88,750 Unchanged (€ 0) Unchanged	€ 198,500 Dividend 2024: € 198,500 ▲ 124% vs 2023 (€ 88,750) Unchanged	€ 307,000 Dividend 2025: € 307,000 ▲ 55% vs 2024 (€ 198,500) Unchanged	▲ 55%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 1,318,351 Bank debt 2024: € 1,318,351 Unchanged (€ 0) Unfavourable step	€ 1,238,297 Bank debt 2025: € 1,238,297 ▼ 6% vs 2024 (€ 1,318,351) Favourable step	▼ 6%
Balance sheet total	€ 108,345 Balance sheet total 2022: € 108,345 First fiscal year in the series	€ 151,582 Balance sheet total 2023: € 151,582 ▲ 40% vs 2022 (€ 108,345) Unchanged	€ 1,515,343 Balance sheet total 2024: € 1,515,343 ▲ € 1.4 million vs 2023 (€ 151,582) Unchanged	€ 1,444,215 Balance sheet total 2025: € 1,444,215 ▼ 5% vs 2024 (€ 1,515,343) Unchanged	▼ 5%

Key figures of Dr. Thomas Verschueren, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Thomas Verschueren?

What happened at Dr. Thomas Verschueren in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 17, 2026 New annual accounts for financial year 2025: profit of € 190,600 (▼ 9% vs 2024). filed late Source: NBB ↗
Jan 19, 2021 New establishment in Kortrijk. KBO
Jan 19, 2021 Start of the company according to the CBE. KBO
2021 Thomas VERSCHUEREN became a director. NBB

In short

From € 50,441 profit in 2022 to € 190,600 profit in 2025.

Paid € 184,397 in corporate taxes since 2022.

Best year ever: 2024, with € 209,700 profit.

Paid out € 594,250 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Thomas Verschueren? We notify you, reason included.

Follow Dr. Thomas Verschueren

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Thomas VERSCHUEREN

Dr. Thomas Verschueren

Behind Dr. Thomas Verschueren is Thomas VERSCHUEREN.

See the full network in the app

Directors

According to the 2025 annual accounts

Thomas VERSCHUEREN

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Koning Albertpark(Kor) 29

8500 Kortrijk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ADVOCATEN LDC

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0761.796.824
VAT number: BE 0761.796.824
Registered office: Koning Albertpark(Kor) 29, 8500 Kortrijk
Names & denominations: Dr. Thomas Verschueren
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 January 2021
Peppol: Active · Active since 10 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗